European Archives - Page 14 of 1193 - European Medical Journal

Novel Imaging of Spinal Lesions in Axial and Peripheral Arthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that can lead to irreversible structural damage…

Norwegian Data on Birth Factors and Juvenile Idiopathic Arthritis Risk

Most studies on juvenile idiopathic arthritis (JIA) aetiology are case-control studies, which are susceptible to recall and selection bias…

IFN-Stimulated Genes Mark Preclinical Synovitis in Anti-CCP+ Individuals

In individuals who are anti-citrullinated peptide positive (anti-CCP+) at risk of developing rheumatoid arthritis (RA), ultrasound…

Apl Stimulation Modifies Monocyte Epigenetic Signatures in Patients With OAPS and TAPS

Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterised by the presence of antiphospholipid antibodies…

Psychedelics in Psychiatry: Interview with Christina Dalla

EMJ spoke with Christina Dalla, a pioneering researcher in neuropsychopharmacology and expert in sex differences in neuropsychiatric…

How Does a Late Hypertension Diagnosis Impact Cardiovascular Outcomes?

Delayed hypertension diagnosis increases cardiovascular risk and lowers treatment rates, underscoring the value of prompt clinical action.

Urinalysis Abnormalities Linked to Somatisation in Women Functional Dyspepsia

A new clinical study has identified a potential link between abnormal urinalysis and somatisation symptoms in female patients with epigastric pain syndrome.

HLTH Europe 2025 Interview: Nada Abedin

There are two sides to this. On one hand, I’ve been working in high-stakes specialties with fast-paced environments, such as emergency…

Steven Okoli

Hema Now: Episode 22: The State of Sickle Cell

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

NHS Expands Access to Once-Daily Cystic Fibrosis Treatment

Hundreds of people with cystic fibrosis in England will now have access to a new once-daily triple therapy, expanding treatment to rare genetic types for the first time.